Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin.

Haun F, Neumann S, Peintner L, Wieland K, Habicht J, Schwan C, Østevold K, Koczorowska MM, Biniossek M, Kist M, Busch H, Boerries M, Davis RJ, Maurer U, Schilling O, Aktories K, Borner C.

Nat Commun. 2018 Aug 30;9(1):3524. doi: 10.1038/s41467-018-05850-w.

2.

Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing.

Blümel B, Goelz H, Kist M, Glocker EO.

Helicobacter. 2018 Aug;23(4):e12494. doi: 10.1111/hel.12494. Epub 2018 Jun 6.

PMID:
29873430
3.

Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death.

de Almagro MC, Goncharov T, Izrael-Tomasevic A, Duttler S, Kist M, Varfolomeev E, Wu X, Lee WP, Murray J, Webster JD, Yu K, Kirkpatrick DS, Newton K, Vucic D.

Cell Death Differ. 2017 Jan;24(1):26-37. doi: 10.1038/cdd.2016.78. Epub 2016 Aug 12.

4.

Aegle marmelos fruit extract attenuates Helicobacter pylori Lipopolysaccharide induced oxidative stress in Sprague Dawley rats.

Ramakrishna YG, Savithri K, Kist M, Devaraj SN.

BMC Complement Altern Med. 2015 Oct 19;15:375. doi: 10.1186/s12906-015-0915-x.

5.

Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testing.

Draeger S, Wüppenhorst N, Kist M, Glocker EO.

J Antimicrob Chemother. 2015 Nov;70(11):3141-5. doi: 10.1093/jac/dkv223. Epub 2015 Aug 5.

PMID:
26245638
6.

Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany.

Wüppenhorst N, Draeger S, Stüger HP, Hobmaier B, Vorreiter J, Kist M, Glocker EO; ResiNet Study Group.

J Antimicrob Chemother. 2014 Nov;69(11):3127-33. doi: 10.1093/jac/dku243. Epub 2014 Jul 4.

PMID:
24997315
7.

High secondary resistance to quinolones in German Helicobacter pylori clinical isolates.

Wueppenhorst N, Stueger HP, Kist M, Glocker EO.

J Antimicrob Chemother. 2013 Jul;68(7):1562-6. doi: 10.1093/jac/dkt061. Epub 2013 Mar 5.

PMID:
23463210
8.

Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin.

Sakinc T, Baars B, Wüppenhorst N, Kist M, Huebner J, Opferkuch W.

BMC Res Notes. 2012 Oct 30;5:603. doi: 10.1186/1756-0500-5-603.

9.

Culture of a gastric non-Helicobacter pylori Helicobacter from the stomach of a 14-year-old girl.

Wüppenhorst N, von Loewenich F, Hobmaier B, Vetter-Knoll M, Mohadjer S, Kist M.

Helicobacter. 2013 Feb;18(1):1-5. doi: 10.1111/j.1523-5378.2012.00990.x. Epub 2012 Aug 21.

PMID:
23067246
10.

Culture and successful eradication of Helicobacter pylori from heterotopic gastric mucosa.

Wüppenhorst N, Viebahn B, Theile A, Radü HJ, Kist M.

Z Gastroenterol. 2012 Jul;50(7):677-9. doi: 10.1055/s-0031-1299382. Epub 2012 Jul 3.

PMID:
22760679
11.

[Differences of vacA alleles and cagA gene positivity of Helicobacter pylori strains isolated from two different countries: Turkey and Germany].

Kolaylı F, Karadenizli A, Bingöl R, Schneider T, Kist M.

Mikrobiyol Bul. 2012 Apr;46(2):332-4. Turkish.

PMID:
22639323
12.

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.

Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y; Study Group participants.

Gut. 2013 Jan;62(1):34-42. doi: 10.1136/gutjnl-2012-302254. Epub 2012 May 12.

PMID:
22580412
13.

Is Helicobacter pylori resident or transient in the human oral cavity?

Al-Ahmad A, Kürschner A, Weckesser S, Wittmer A, Rauberger H, Jakob T, Hellwig E, Kist M, Waidner B.

J Med Microbiol. 2012 Aug;61(Pt 8):1146-52. doi: 10.1099/jmm.0.043893-0. Epub 2012 Apr 12.

PMID:
22499779
14.

[Networks of National Reference Centers and associated Consiliary Laboratories in Germany].

Laude G, Kist M, Krause G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Feb;55(2):223-30. doi: 10.1007/s00103-011-1417-8. German.

PMID:
22290166
15.

Seasonality of Clostridium difficile infections in Southern Germany.

Reil M, Hensgens MP, Kuijper EJ, Jakobiak T, Gruber H, Kist M, Borgmann S.

Epidemiol Infect. 2012 Oct;140(10):1787-93. doi: 10.1017/S0950268811002627. Epub 2011 Dec 8.

16.

Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011.

Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T, Gärtner B, Gross U, Haas W, Hamouda O, Hübner J, Jänisch T, Kist M, Kramer MH, Ledig T, Mielke M, Pulz M, Stark K, Suttorp N, Ulbrich U, Wichmann O, Krause G.

PLoS One. 2011;6(10):e25691. doi: 10.1371/journal.pone.0025691. Epub 2011 Oct 4.

17.

Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database.

Mitchel JT, Kim YJ, Choi J, Park G, Cappi S, Horn D, Kist M, D Agostino RB Jr.

Drug Inf J. 2011 Jul;45(4):421-430.

18.

Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system.

Reil M, Erhard M, Kuijper EJ, Kist M, Zaiss H, Witte W, Gruber H, Borgmann S.

Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1431-6. doi: 10.1007/s10096-011-1238-6. Epub 2011 Apr 20.

19.

Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany.

Wüppenhorst N, Lenze F, Ross M, Kist M.

J Antimicrob Chemother. 2011 Jan;66(1):222-3. doi: 10.1093/jac/dkq405. Epub 2010 Nov 3. No abstract available.

PMID:
21051371
20.

[Emergence of clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics].

Jansen A, Kleinkauf N, Weiss B, Zaiss NH, Witte W, Bornhofen B, Kist M, von Eichel-Streiber C, Neumann M, Michels H, Eckmanns T.

Z Gastroenterol. 2010 Sep;48(9):1120-5. doi: 10.1055/s-0029-1245269. Epub 2010 Sep 13. German.

PMID:
20839161
21.

Correlations between bed occupancy rates and Clostridium difficile infections: a time-series analysis.

Kaier K, Luft D, Dettenkofer M, Kist M, Frank U.

Epidemiol Infect. 2011 Mar;139(3):482-5. doi: 10.1017/S0950268810001214. Epub 2010 Jun 1.

PMID:
20513253
22.

[Clostridium difficile infection].

Grünewald T, Kist M, Mutters R, Ruf BR, Kern WV.

Dtsch Med Wochenschr. 2010 Apr;135(14):699-703. doi: 10.1055/s-0030-1251918. Epub 2010 Mar 31. Review. German. No abstract available.

PMID:
20358497
23.

Re: the impact of the stone age diet on gingival conditions in the absence of oral hygiene. Baumgartner S, Imfeld T, Schicht O, Rath C, Persson RE, Persson GR. (J Periodontol 2009;80:759-768.).

Al-Ahmad A, Hellwig E, Wittmer A, Kist M, Waidner B.

J Periodontol. 2010 Mar;81(3):338; author reply 338-9. doi: 10.1902/jop.2010.090546. No abstract available.

PMID:
20192855
24.

Letter to the Editor: Re: "The Impact of the Stone Age Diet on Gingival Conditions in the Absence of Oral Hygiene".

Al-Ahmad A, Hellwig E, Wittmer A, Kist M, Waidner B.

J Periodontol. 2010 Mar;81(3):338. doi: 10.1902/jop.2010.090546. No abstract available.

PMID:
29537554
25.

Association of ciprofloxacin prescriptions to outpatients to Clostridium difficile infections.

Borgmann S, Jakobiak T, Gruber H, Reil M, Schroder H, Kist M, Sagel U.

Euro Surveill. 2010 Feb 4;15(5). pii: 19479.

26.

Helicobacter pylori and gastroduodenal ulcer disease.

Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Kist M, Koletzko S; Association of Scientific Medical Societies.

Dtsch Arztebl Int. 2009 Dec;106(49):801-8. doi: 10.3238/arztebl.2009.0801. Epub 2009 Dec 4.

27.

S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001.

Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Bornschein J, Götze O, Höhne W, Kist M, Koletzko S, Labenz J, Layer P, Miehlke S, Morgner A, Peitz U, Preiss J, Prinz C, Rosien U, Schmidt W, Schwarzer A, Suerbaum S, Timmer A, Treiber G, Vieth M; German society for hygiene and microbiology; German society for pediatric gastroenterology and nutrition e. V; German society for rheumatology.

Z Gastroenterol. 2009 Dec;47(12):1230-63. doi: 10.1055/s-0028-1109855. Epub 2009 Dec 3.

PMID:
19960402
28.

A novel system of cytoskeletal elements in the human pathogen Helicobacter pylori.

Waidner B, Specht M, Dempwolff F, Haeberer K, Schaetzle S, Speth V, Kist M, Graumann PL.

PLoS Pathog. 2009 Nov;5(11):e1000669. doi: 10.1371/journal.ppat.1000669. Epub 2009 Nov 20.

29.

Helicobacter pylori multiplex serology.

Michel A, Waterboer T, Kist M, Pawlita M.

Helicobacter. 2009 Dec;14(6):525-35. doi: 10.1111/j.1523-5378.2009.00723.x.

PMID:
19889070
30.

[Establishment of Networks of National Reference Centres and associated Consiliary Laboratories in Germany].

Laude G, Kist M, Krause G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Oct;52(10):919-26. doi: 10.1007/s00103-009-0943-0. German.

PMID:
19760248
31.

Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.

Wueppenhorst N, Stueger HP, Kist M, Glocker E.

J Antimicrob Chemother. 2009 Apr;63(4):648-53. doi: 10.1093/jac/dkp003. Epub 2009 Feb 3.

PMID:
19190100
32.

[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"].

Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Bornschein J, Götze O, Höhne W, Kist M, Koletzko S, Labenz J, Layer P, Miehlke S, Morgner A, Peitz U, Preiss JC, Prinz C, Rosien U, Schmidt WE, Schwarzer A, Suerbaum S, Timmer A, Treiber G, Vieth M.

Z Gastroenterol. 2009 Jan;47(1):68-102. doi: 10.1055/s-0028-1109062. Epub 2009 Jan 20. German.

PMID:
19156594
33.

Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany.

Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, Gruber H, Brazier JS, Schulte B.

Euro Surveill. 2008 Dec 4;13(49). pii: 19057.

34.

Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats.

Devi RS, Kist M, Vani G, Devi CS.

J Pharm Pharmacol. 2008 Apr;60(4):505-14. doi: 10.1211/jpp.60.4.0014.

PMID:
18380924
35.

Antimicrobial resistance in Escherichia coli strains isolated from food, animals and humans in Germany.

Meyer E, Lunke C, Kist M, Schwab F, Frank U.

Infection. 2008 Feb;36(1):59-61. doi: 10.1007/s15010-007-7113-9. Epub 2007 Dec 28.

PMID:
18165861
36.

Travel-related Salmonella agama, Gabon.

Bélard S, Kist M, Ramharter M.

Emerg Infect Dis. 2007 May;13(5):790-1. No abstract available.

37.

Helicobacter pylori: primary antimicrobial resistance and first-line treatment strategies.

Kist M.

Euro Surveill. 2007 Jul 1;12(7):E1-2. No abstract available.

PMID:
17991405
38.

Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections.

Wassenaar TM, Kist M, de Jong A.

Int J Antimicrob Agents. 2007 Sep;30(3):195-201. Epub 2007 Apr 8. Review.

PMID:
17420115
39.

Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.

Glocker E, Bogdan C, Kist M.

J Antimicrob Chemother. 2007 May;59(5):874-9. Epub 2007 Mar 9.

PMID:
17350989
40.

Quinolone resistance in Helicobacter pylori isolates in Germany.

Glocker E, Stueger HP, Kist M.

Antimicrob Agents Chemother. 2007 Jan;51(1):346-9. Epub 2006 Oct 16.

41.

Impact of German National Reference Centres on monitoring of antibiotic resistance.

Kist M.

Int J Med Microbiol. 2006 Jun;296 Suppl 41:55-61.

PMID:
17024755
42.

Emergence of a Helicobacter pylori isolate with reduced susceptibility to tetracycline in Germany.

Glocker E, Kist M.

J Antimicrob Chemother. 2006 Nov;58(5):1103-4. Epub 2006 Aug 18. No abstract available.

PMID:
16920745
43.

The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization.

Stähler FN, Odenbreit S, Haas R, Wilrich J, Van Vliet AH, Kusters JG, Kist M, Bereswill S.

Infect Immun. 2006 Jul;74(7):3845-52.

44.

Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study.

Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, Stolte M, Jauch KW, Hatz RA.

Lancet Oncol. 2006 Mar;7(3):211-22.

PMID:
16510330
45.

How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection?

Kist M.

Nat Clin Pract Gastroenterol Hepatol. 2005 Oct;2(10):450-1. No abstract available.

PMID:
16224475
46.

Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori.

Glocker E, Berning M, Gerrits MM, Kusters JG, Kist M.

Antimicrob Agents Chemother. 2005 Aug;49(8):3166-70.

47.

[Pathogenesis, diagnostics and treatment of Helicobacter pylori infection].

Kist M, Glocker E, Suerbaum S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Jun;48(6):669-78. Review. German.

PMID:
15983844
48.
49.

Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur.

Ernst FD, Homuth G, Stoof J, Mäder U, Waidner B, Kuipers EJ, Kist M, Kusters JG, Bereswill S, van Vliet AH.

J Bacteriol. 2005 Jun;187(11):3687-92.

50.

Mutational analysis of the Helicobacter pylori carbonic anhydrases.

Stähler FN, Ganter L, Lederer K, Kist M, Bereswill S.

FEMS Immunol Med Microbiol. 2005 May 1;44(2):183-9.

Supplemental Content

Support Center